Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Generate Biomedicines, Inc. | 724,160 | reported | 02 Mar 2026 | tx 3+753,721−1,100,000 |
| Moderna, Inc. | 250,932 | reported | 01 Mar 2026 | tx 1699+21,998,110−27,819,138 |
| Targanta Therapeutics Corp. | 25,000 | reported | 25 Aug 2008 | tx 1+25,000 |
| Syros Pharmaceuticals, Inc. | 22,000 | reported | 15 Sept 2016 | tx 3+48,666−100,000 |
| BG Medicine, Inc. | 4,205 | reported | 03 Jun 2014 | tx 14+564,882 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Mar 2026 | GRANT_AWARD | Moderna, Inc. | 250,932 | 0.00 USD | deriv |
| 02 Mar 2026 | CONVERSION | Generate Biomedicines, Inc. | 724,160 | — | |
| 26 Feb 2026 | GRANT_AWARD | Generate Biomedicines, Inc. | 29,561 | 0.00 USD | deriv |
| 02 Mar 2026 | CONVERSION | Generate Biomedicines, Inc. | 1,100,000 | 0.00 USD | deriv |
| 11 Feb 2026 | TAX_WITHHOLDING | Moderna, Inc. | 5,450 | 41.99 USD | |
| 11 Feb 2026 | GRANT_AWARD | Moderna, Inc. | 11,271 | 0.00 USD | |
| 11 Dec 2025 | EXERCISE | Moderna, Inc. | 688,073 | 10.90 USD | |
| 11 Dec 2025 | EXERCISE | Moderna, Inc. | 688,073 | 0.00 USD | deriv |
| 03 Mar 2025 | PURCHASE | Moderna, Inc. | 102,821 | 31.04 USD | first after silence |
| 03 Mar 2025 | PURCHASE | Moderna, Inc. | 57,493 | 31.53 USD | |
| 01 Mar 2025 | GRANT_AWARD | Moderna, Inc. | 357,065 | 0.00 USD | deriv |
| 12 Feb 2025 | TAX_WITHHOLDING | Moderna, Inc. | 6,400 | 30.93 USD | |
| 12 Feb 2025 | GRANT_AWARD | Moderna, Inc. | 13,233 | 0.00 USD | |
| 14 Jun 2024 | OTHER | Moderna, Inc. | 26,840 | 0.00 USD | |
| 27 Feb 2024 | GRANT_AWARD | Moderna, Inc. | 151,943 | 0.00 USD | deriv |
| 14 Feb 2024 | GRANT_AWARD | Moderna, Inc. | 56,736 | 0.00 USD | |
| 16 Feb 2024 | SALE | Moderna, Inc. | 26,351 | 88.88 USD | |
| 15 Sept 2023 | OTHER | Moderna, Inc. | 17,893 | 0.00 USD | |
| 28 Jun 2023 | SALE | Moderna, Inc. | 13,094 | 122.01 USD | |
| 28 Jun 2023 | SALE | Moderna, Inc. | 11,417 | 121.40 USD | |
| 28 Jun 2023 | SALE | Moderna, Inc. | 2,278 | 120.39 USD | |
| 28 Jun 2023 | EXERCISE | Moderna, Inc. | 27,155 | 0.99 USD | |
| 28 Jun 2023 | SALE | Moderna, Inc. | 366 | 123.05 USD | |
| 28 Jun 2023 | EXERCISE | Moderna, Inc. | 27,155 | 0.00 USD | deriv |
| 22 Jun 2023 | EXERCISE | Moderna, Inc. | 40,000 | 0.99 USD |
1 purchase reported after at least 12 months of silence — most recent on 03 Mar 2025.